- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT06049017
A Study of JNJ-77242113 in Participants With Moderately to Severely Active Ulcerative Colitis (ANTHEM-UC)
March 26, 2024 updated by: Janssen Research & Development, LLC
A Phase 2b Multicenter, Randomized, Placebo- Controlled, Dose-Ranging Study to Evaluate the Efficacy and Safety of JNJ-77242113 for the Treatment of Moderately to Severely Active Ulcerative Colitis
The purpose of this study is to evaluate the safety and effectiveness of JNJ-77242113 compared with placebo in participants with moderately to severely active ulcerative colitis.
Study Overview
Status
Recruiting
Conditions
Intervention / Treatment
Study Type
Interventional
Enrollment (Estimated)
240
Phase
- Phase 2
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Contact
- Name: Study Contact
- Phone Number: 844-434-4210
- Email: Participate-In-This-Study@its.jnj.com
Study Locations
-
-
-
Buenos Aires, Argentina, B1878DVB
- Recruiting
- Cer Instituto Medico
-
Buenos Aires, Argentina, C1125
- Recruiting
- Gedyt - Consultorios Gastroenterologia
-
Ciudad Autonoma de Buenos Aires, Argentina, C1061AAS
- Recruiting
- CIPREC
-
Rosario, Argentina, S2000KDS
- Recruiting
- Hospital Provincial del Centenario
-
San Miguel de Tucuman, Argentina, 4000
- Recruiting
- Sanatorio 9 de Julio
-
-
-
-
-
Birtinya, Australia, 4575
- Recruiting
- Sunshine Coast University Hospital
-
Blacktown, Australia, 2148
- Recruiting
- Blacktown Hospital
-
Concord, Australia, 2139
- Recruiting
- Concord Repatriation General Hospital
-
Wollongong, Australia, 2500
- Recruiting
- Wollongong Private Hospital
-
-
-
-
-
Brussels, Belgium, 1000
- Recruiting
- CHU Saint-Pierre
-
Gent, Belgium, 9000
- Recruiting
- Ghent University Hospital
-
Gent, Belgium, 9000
- Recruiting
- AZ Sint-Lucas
-
Leuven, Belgium, 3000
- Recruiting
- Universitair Ziekenhuis Leuven
-
Liege, Belgium, 4000
- Recruiting
- Centre Hospitalier Universitaire de Liege Domaine Universitaire du Sart Tilman
-
Sint-Niklaas, Belgium, 9100
- Recruiting
- Vitaz
-
-
-
-
-
Botucatu, Brazil, 18618-687
- Recruiting
- UNESP - Faculdade de Medicina da Universidade Estadual Paulista - Campus Botucatu
-
Brasília, Brazil, 70.200-730
- Recruiting
- L2IP Instituto de Pesquisas Clinicas
-
Curitiba, Brazil, 80430-180
- Recruiting
- CDC - Centro Digestivo de Curitiba
-
Santo Andre, Brazil, 09080-110
- Recruiting
- Pesquisare Saúde
-
Sao Paulo, Brazil, 01236030
- Recruiting
- BR TRIALS-Ensaios Clinicos e Consultoria Ltda
-
Sao Paulo, Brazil, 01401-002
- Recruiting
- Instituto D Or de Pesquisa e Ensino
-
Votuporanga, Brazil, 15501-405
- Recruiting
- Integral Pesquisa e Ensino
-
-
-
-
Alberta
-
Edmonton, Alberta, Canada, T5R 1W2
- Recruiting
- Gastroenterology and Internal Medicine Research Institute (GIRI)
-
-
Ontario
-
Barrie, Ontario, Canada, L4M 7G1
- Recruiting
- Barrie GI Associates
-
London, Ontario, Canada, N6A 5A5
- Recruiting
- London Health Sciences Centre
-
Oakville, Ontario, Canada, L6L 5L7
- Recruiting
- ABP Research Services Corp.
-
-
-
-
-
Changsha, China, 410011
- Recruiting
- The Second Xiangya Hospital of Central South University
-
Chongqing, China, 400014
- Recruiting
- Chongqing General Hospital
-
Guangzhou, China, 510060
- Recruiting
- The First Affiliated Hospital, Sun Yat-sen University
-
Guangzhou, China, 510655
- Recruiting
- The Sixth Affiliated Hospital Sun Yat sen University
-
Hangzhou, China, 310000
- Recruiting
- Sir Run Run Shaw Hospital, Zhejiang University School of Medicine
-
Jinan, China, 250012
- Recruiting
- Qilu Hospital of Shandong University
-
Lan Zhou, China, 730031
- Recruiting
- Lanzhou University Second Hospital
-
Nan Jing Shi, China, 210008
- Recruiting
- Nanjing Drum Tower Hospital
-
Shen Yang Shi, China, 110022
- Recruiting
- Shengjing Hospital of China Medical University
-
Wuhan, China, 430022
- Recruiting
- Union Hospital Tongji Medical College of Huazhong University of Science and Technology
-
Wuxi, China, 214023
- Recruiting
- Wuxi People s Hospital
-
Xi'An, China, 710038
- Recruiting
- The Second Affiliated Hospital of Air Force Medical University - Tangdu Hospital
-
-
-
-
-
Ceske Budejovice, Czechia, 370 01
- Recruiting
- Nemocnice Ceske Budejovice
-
Hradec Kralova, Czechia, 500 02
- Recruiting
- Gastroenterologie, s.r.o., Hradec Kralove
-
Hradec Kralove, Czechia, 500 12
- Recruiting
- Hepato-Gastroenterologie HK, s.r.o.
-
Praha, Czechia, 19000
- Recruiting
- ISCARE a.s.
-
Slany, Czechia, 27401
- Recruiting
- Nemocnice Slany
-
-
-
-
-
Besancon Cedex, France, 25030
- Recruiting
- CHRU Besancon Hopital Jean Minjoz
-
Creteil, France, 94000
- Recruiting
- APHP - Hopital Henri Mondor
-
Lille, France, 59037
- Recruiting
- Chru De Lille - Hopital Claude Huriez
-
Nice, France, 06202
- Recruiting
- CHU de Nice Hopital de l Archet
-
Nimes Cedex, France, 30900
- Recruiting
- CHU Nimes Hopital Caremeau
-
Paris, France, 75018
- Recruiting
- APHP - Hopital Bichat - Claude Bernard
-
Pierre Benite, France, 69495
- Recruiting
- Hospices Civils de Lyon CHU Lyon Sud
-
Saint Priest en Jarez, France, 42270
- Recruiting
- CHU Saint-Etienne - Hopital Nord
-
Toulouse, France, 31400
- Recruiting
- CHU Toulouse - Hôpital de Rangueil
-
Vandœuvre-les-Nancy, France, 54500
- Recruiting
- CHU de Nancy_ Hopital Brabois
-
-
-
-
-
Augsburg, Germany, D-86158
- Recruiting
- Klinikum Augsburg
-
Berlin, Germany, 14163
- Recruiting
- Krankenhaus Waldfriede Mitte
-
Dresden, Germany, 01307
- Recruiting
- Universitaetsklinikum Carl Gustav Carus TU Dresden
-
Kiel, Germany, 24105
- Recruiting
- Universitatsklinikum Schleswig Holstein Kiel
-
Leipzig, Germany, 04103
- Recruiting
- EUGASTRO GmbH
-
Lueneburg, Germany, 21339
- Recruiting
- Staedtisches Klinikum Lueneburg
-
Minden, Germany, 32423
- Recruiting
- Gastroenterologische Gemeinschaftspraxis Minden
-
-
-
-
-
Budapest, Hungary, 1088
- Recruiting
- Semmelweis Egyetem
-
Budapest, Hungary, 1083
- Recruiting
- Semmelweis Egyetem
-
Budapest, Hungary, H-1136
- Recruiting
- Pannónia Magánorvosi Centrum Kft
-
Debrecen, Hungary, 4025
- Recruiting
- Vasutegeszsegugyi Nonprofit Kozhasznu Kft.
-
Debrecen, Hungary, 4032
- Recruiting
- Debreceni Egyetem Gasztroenterologiai Klinika
-
Gyongyos, Hungary, 3200
- Recruiting
- Clinexpert Kft
-
-
-
-
-
Jaipur, India, 302006
- Recruiting
- S. R. Kalla Memorial General Hospital
-
Surat, India, 395002
- Recruiting
- SIDS Hospital & Research Centre
-
-
-
-
-
Milano, Italy, 20132
- Recruiting
- Ospedale San Raffaele di Milano
-
Milano, Italy, 20122
- Recruiting
- Fondazione IRCCS Ca Granda, Ospedale Policlinico di Milano
-
Negrar Di Valpolicella, Italy, 37024
- Recruiting
- Ospedale Sacro Cuore Don Calabria
-
Roma, Italy, 00168
- Recruiting
- Fondazione Policlinico Universitario A Gemelli IRCCS
-
Roma, Italy, 00152
- Recruiting
- Azienda Ospedaliera San Camillo - Roma
-
Rozzano, Italy, 20089
- Recruiting
- Istituto Clinico Humanitas
-
San Giovanni Rotondo, Italy, 71013
- Recruiting
- Casa Sollievo della Sofferenza, IRCCS
-
-
-
-
-
Fujiidera-shi, Japan, 583-0027
- Recruiting
- Sai Clinic, Gastrointestinal and Protology Divisions
-
Hamamatsu, Japan, 431 3192
- Recruiting
- Hamamatsu University Hospital
-
Kagoshima, Japan, 892-0843
- Recruiting
- Kagoshima IBD Gastroenterology Clinic
-
Kashiwa, Japan, 277-0871
- Recruiting
- Tsujinaka Hospital Kashiwanoha
-
Kobe, Japan, 650-0015
- Recruiting
- Aoyama Naika Clinic
-
Osaka, Japan, 543-8555
- Recruiting
- Japanese Red Cross Osaka Hospital
-
Osaka, Japan, 530-0011
- Recruiting
- Kinshukai Infusion Clinic
-
Sakura, Japan, 285-8741
- Recruiting
- Toho University Sakura Medical Center
-
Sapporo, Japan, 004-0041
- Recruiting
- Sapporo Tokushukai Hospital
-
Sapporo, Japan, 065-0033
- Recruiting
- Sapporo Higashi Tokushukai Hospital
-
Shimizu, Japan, 411-8611
- Recruiting
- National Hospital Organization Shizuoka Medical Center
-
Tsu, Japan, 514 8507
- Recruiting
- Mie University Hospital
-
Yokohama, Japan, 232 0024
- Recruiting
- Yokohama City University Medical Center
-
-
-
-
-
Busan, Korea, Republic of, 48108
- Recruiting
- Inje University Haeundae Paik Hospital
-
Daegu, Korea, Republic of, 42415
- Recruiting
- Yeungnam University Hospital
-
Seoul, Korea, Republic of, 03080
- Recruiting
- Seoul National University Hospital
-
Seoul, Korea, Republic of, 05505
- Recruiting
- Asan Medical Center
-
Seoul, Korea, Republic of, 06351
- Recruiting
- Samsung Medical Center
-
Seoul, Korea, Republic of, 03181
- Recruiting
- Kangbuk Samsung Hospital
-
Suwon-si, Korea, Republic of, 16247
- Recruiting
- The Catholic University of Korea, St. Vincent's Hospital
-
-
-
-
-
Johor Bahru, Malaysia, 80100
- Recruiting
- Hospital Sultanah Aminah
-
Kajang, Malaysia, 43000
- Recruiting
- Sultan Idris Shah Hospital
-
Kuala Lumpur, Malaysia, 59100
- Recruiting
- University Malaya Medical Centre
-
-
-
-
-
Bydgoszcz, Poland, 85-168
- Recruiting
- Szpital Uniwersytecki nr 2 im dr Jana Biziela w Bydgoszczy
-
Chojnice, Poland, 89-600
- Recruiting
- Centrum Medyczne Lukamed
-
Krakow, Poland, 30 363
- Recruiting
- Centrum Medyczne Plejady
-
Rzeszow, Poland, 35-326
- Recruiting
- Centrum Medyczne Medyk
-
Szczecin, Poland, 71-685
- Recruiting
- Sonomed Sp. Z O.O.
-
Torun, Poland, 87-100
- Recruiting
- Gastromed Sp. z o.o.
-
Warszawa, Poland, 02-507
- Recruiting
- Centralny Szpital Kliniczny MSWiA
-
Warszawa, Poland, 03-712
- Recruiting
- Bodyclinic Sp. z o.o. sp. k
-
Warszawa, Poland, 04 501
- Recruiting
- Medical Network Spolka z o.o. WIP Warsaw IBD Point Profesor Kierkus
-
Wroclaw, Poland, 52-416
- Recruiting
- Centrum Medyczne Oporow
-
Wroclaw, Poland, 50-449
- Recruiting
- Melita Medical Sp. z o.o.
-
Wroclaw, Poland, 54-144
- Recruiting
- EMC Instytut Medyczny SA
-
-
-
-
-
Bucuresti, Romania, 013823
- Recruiting
- Spital Memorial
-
Bucuresti, Romania, 014146
- Recruiting
- S C Delta Health Care S R L
-
Cluj-Napoca, Romania, 400061
- Recruiting
- Digenio - Centrul Medical de Gastroenterologie, Hepatologie si Endoscopie Digestiva
-
Ploiesti, Romania, 100032
- Recruiting
- Centrul Medical Valahia
-
-
-
-
-
Alcorcon, Spain, 28922
- Recruiting
- Hosp. Univ. Fundacion Alcorcon
-
Gijon, Spain, 33394
- Recruiting
- Hosp. de Cabuenes
-
Madrid, Spain, 28046
- Recruiting
- Hosp. Univ. La Paz
-
Majadahonda, Spain, 28222
- Recruiting
- Hosp. Univ. Pta. de Hierro Majadahonda
-
Santiago de Compostela, Spain, 15706
- Recruiting
- Hosp. Clinico Univ. de Santiago
-
Sevilla, Spain, 41009
- Recruiting
- Hosp. Virgen Macarena
-
Sevilla, Spain, 41014
- Recruiting
- Hosp. Ntra. Sra. de Valme
-
Valencia, Spain, 46010
- Recruiting
- Hosp. Clinico Univ. de Valencia
-
Valencia, Spain, 46026
- Recruiting
- Hosp. Univ. I Politecni La Fe
-
Vigo, Spain, 36312
- Recruiting
- Hosp. Alvaro Cunqueiro
-
-
-
-
-
Ankara, Turkey, 6500
- Recruiting
- Gazi University Medical Faculty
-
Bursa, Turkey, 16059
- Recruiting
- Uludag Universitesi Tıp Fakultesi Hastanesi
-
Izmir, Turkey, 35040
- Recruiting
- Ege Universitesi Tip Fakultesi
-
Mersin, Turkey, 33343
- Recruiting
- Mersin University Medical Faculty
-
-
-
-
-
Bury, United Kingdom, Greater Manchester
- Recruiting
- Fairfield General Hospital
-
Cambridge, United Kingdom, CB2 0QQ
- Recruiting
- Addenbrookes Hospital
-
London, United Kingdom, SW17 0RE
- Recruiting
- St George's University Hospital NHS Foundation Trust
-
London, United Kingdom, E11 1NR
- Recruiting
- Barts Health Nhs Trust
-
Oxford, United Kingdom, OX3 9DU
- Recruiting
- Oxford University Hospitals Nhs Foundation Trust
-
Prescot, United Kingdom, L35 5DR
- Recruiting
- Whiston Hospital
-
-
-
-
California
-
Orange, California, United States, 92868
- Recruiting
- Clinnova Research
-
San Diego, California, United States, 92123
- Recruiting
- Medical Associates Research Group, Inc.
-
-
Colorado
-
Colorado Springs, Colorado, United States, 80907
- Recruiting
- Peak Gastroenterology Associates
-
-
Florida
-
Kissimmee, Florida, United States, 34741
- Recruiting
- I.H.S. Health. LLC
-
Orlando, Florida, United States, 32803-1853
- Recruiting
- Endoscopic Research Inc
-
-
Georgia
-
Atlanta, Georgia, United States, 30342
- Recruiting
- Atlanta Gastroenterology Associates
-
-
Indiana
-
New Albany, Indiana, United States, 47150
- Recruiting
- Gastroenterology of Southern Indiana
-
-
Kansas
-
Topeka, Kansas, United States, 66606
- Recruiting
- Cotton O'Neil Digestive Health Center
-
-
Louisiana
-
Marrero, Louisiana, United States, 70072
- Recruiting
- Tandem Clinical Research
-
-
Maryland
-
Baltimore, Maryland, United States, 21202-2102
- Recruiting
- Mercy Medical Center
-
-
New York
-
New York, New York, United States, 10075
- Recruiting
- New York Gastroenterology Associates
-
North Massapequa, New York, United States, 11758
- Recruiting
- DiGiovanna Institute for Medical Education & Research
-
-
North Carolina
-
Chapel Hill, North Carolina, United States, 27599
- Recruiting
- University North Carolina at Chapel Hill
-
Charlotte, North Carolina, United States, 28207
- Recruiting
- Charlotte Gastroenterology and Hepatology, PLLC
-
Charlotte, North Carolina, United States, 28204
- Recruiting
- Atrium Health
-
-
Ohio
-
Westlake, Ohio, United States, 44145
- Recruiting
- Northshore Gastroenterology Research, LLC
-
-
Oklahoma
-
Oklahoma City, Oklahoma, United States, 73112
- Recruiting
- Digestive Disease Specialists Inc
-
-
Texas
-
Austin, Texas, United States, 78705
- Recruiting
- Amel Med LLC. Research
-
Humble, Texas, United States, 77346
- Recruiting
- Accurate Clinical Research, Inc.
-
Lubbock, Texas, United States, 79424
- Recruiting
- Caprock Gastro Research
-
San Antonio, Texas, United States, 78229
- Recruiting
- Southern Star Research Institute, LLC
-
Tyler, Texas, United States, 75701
- Recruiting
- Tyler Research Institute, LLC
-
-
Utah
-
Ogden, Utah, United States, 84403
- Recruiting
- Care Access Research, Ogden
-
-
Virginia
-
Chesapeake, Virginia, United States, 23320
- Recruiting
- Gastroenterology Associates of Tidewater
-
-
Washington
-
Bellevue, Washington, United States, 98004
- Recruiting
- Washington Gastroenterology, PLLC
-
Tacoma, Washington, United States, 98405
- Recruiting
- Washington Gastroenterology, PLLC
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
- Adult
- Older Adult
Accepts Healthy Volunteers
No
Description
Inclusion Criteria:
- Signed informed consent form 18 years of age or older
- Documented diagnosis of ulcerative colitis (UC) of at least 12 weeks prior to screening
- Moderately to severely active UC as per the modified Mayo score
- Demonstrated inadequate response to or intolerance of conventional therapy and/or advanced therapy as defined in the protocol
Exclusion Criteria:
- Participants with current or prior diagnosis of fulminant colitis and/or toxic megacolon
- UC limited to rectum only or to less than (<) 15 centimeters (cm) of colon
- Presence of a stoma
- Presence or history of fistula
- History of extensive colonic resection (example, <30 cm of colon remaining)
- Diagnosis of indeterminate colitis, microscopic colitis, ischemic colitis, Crohn's colitis or clinical findings suggestive of Crohn's disease
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Double
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: Group 1: JNJ-77242113 Dose-1
Participants will receive JNJ-77242113 Dose-1 tablets orally from Week 0 through Week 28.
Participants who complete the Week 28 assessments and have achieved clinical response at Week 28 and who, in the opinion of the investigator, will continue to benefit from treatment with study intervention will continue in the 48-week long term extension (LTE) period and receive the same treatment up to Week 76.
|
JNJ-77242113 tablet will be administered orally.
|
Experimental: Group 2: JNJ-77242113 Dose-2
Participants will receive JNJ-77242113 Dose-2 tablets orally from Week 0 through Week 28.
Participants who complete the Week 28 assessments and have achieved clinical response at Week 28 and who, in the opinion of the investigator, will continue to benefit from treatment with study intervention will continue in the 48-week LTE period and receive the same treatment up to Week 76.
|
JNJ-77242113 tablet will be administered orally.
|
Experimental: Group 3: JNJ-77242113 Dose-3
Participants will receive JNJ-77242113 Dose-3 tablets orally from Week 0 through Week 28.
Participants who complete the Week 28 assessments and have achieved clinical response at Week 28 and who, in the opinion of the investigator, will continue to benefit from treatment with study intervention will continue in the 48-week LTE period and receive the same treatment up to Week 76.
|
JNJ-77242113 tablet will be administered orally.
|
Experimental: Group 4: Placebo
Participants will receive placebo tablets orally from Week 0 through Week 28.
Placebo-treated participants who meet the criteria of inadequate response at Week 16, will receive JNJ-77242113 Dose-3 tablet orally through Week 28.
Participants who complete the Week 28 assessments and have achieved clinical response at Week 28 and who, in the opinion of the investigator, will continue to benefit from treatment with study intervention, will continue in the 48-week LTE period and receive the same treatment up to Week 76.
|
JNJ-77242113 tablet will be administered orally.
Placebo tablet will be administered orally.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Percentage of Participants with Clinical Response at Week 12
Time Frame: Week 12
|
Clinical response is defined as decrease from baseline in the modified Mayo score by greater than or equal to (>=) 30 percent (%) and >=2 points, with either a >=1-point decrease from baseline in the rectal bleeding subscore or a rectal bleeding subscore of 0 or 1.
|
Week 12
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Percentage of Participants with Clinical Remission at Week 12
Time Frame: Week 12
|
Clinical remission is defined as stool frequency subscore of 0 or 1, where the stool frequency subscore has not increased from baseline, a rectal bleeding subscore of 0, and an endoscopy subscore of 0 or 1.
|
Week 12
|
Percentage of Participants with Symptomatic Remission at Week 12
Time Frame: Week 12
|
Symptomatic remission is defined as stool frequency subscore of 0 or 1, where the stool frequency subscore has not increased from baseline, and a rectal bleeding subscore of 0.
|
Week 12
|
Percentage of Participants with Endoscopic Improvement at Week 12
Time Frame: Week 12
|
Endoscopic improvement is defined as an endoscopy subscore of 0 or 1.
|
Week 12
|
Percentage of Participants with Histologic-endoscopic Mucosal Improvement at Week 12
Time Frame: Week 12
|
Histologic-endoscopic mucosal improvement is defined as a combination of histologic remission and endoscopic improvement.
Histologic remission and endoscopic improvement are based on the histologic grading and the Mayo endoscopy subscore.
|
Week 12
|
Percentage of Participants with Adverse Events (AE) and Serious Adverse Evets (SAEs)
Time Frame: Up to Week 76
|
An AE is any untoward medical occurrence in a clinical study participant administered a pharmaceutical (investigational or non-investigational) product.
An AE does not necessarily have a causal relationship with the intervention.
A SAE is any untoward medical occurrence that at any dose: results in death; is life-threatening; requires inpatient hospitalization or prolongation of existing hospitalization; results in persistent or significant disability/incapacity; is a congenital anomaly/birth defect; is a suspected transmission of any infectious agent via a medicinal product; is medically important.
|
Up to Week 76
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Investigators
- Study Director: Janssen Research & Development, LLC Clinical Trial, Janssen Research & Development, LLC
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
October 9, 2023
Primary Completion (Estimated)
May 27, 2025
Study Completion (Estimated)
October 6, 2026
Study Registration Dates
First Submitted
September 15, 2023
First Submitted That Met QC Criteria
September 15, 2023
First Posted (Actual)
September 21, 2023
Study Record Updates
Last Update Posted (Actual)
March 28, 2024
Last Update Submitted That Met QC Criteria
March 26, 2024
Last Verified
March 1, 2024
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 77242113UCO2001 (Other Identifier: Janssen Research & Development, LLC)
- 2023-504673-20-00 (Registry Identifier: EUCT number)
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
YES
IPD Plan Description
The data sharing policy of the Janssen Pharmaceutical Companies of Johnson & Johnson is available at www.janssen.com/clinical-trials/transparency.
As noted on this site, requests for access to the study data can be submitted through Yale Open Data Access (YODA) Project site at yoda.yale.edu
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Yes
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Colitis, Ulcerative
-
Ferring PharmaceuticalsCompletedActive Ulcerative Colitis | Remission of Ulcerative ColitisCanada
-
Palatin Technologies, IncRecruitingUlcerative Colitis | Ulcerative Colitis Flare | Ulcerative Colitis Acute | UlcerativeUnited States
-
Theravance BiopharmaCompletedUlcerative Colitis, Active Severe | Ulcerative Colitis, Active ModerateUnited States, Georgia, Moldova, Republic of, Romania
-
Assistance Publique - Hôpitaux de ParisMRSU 938 - Research Center of Saint AntoineNot yet recruitingPediatric Ulcerative Colitis in RemissionFrance
-
Protagonist Therapeutics, Inc.CompletedUlcerative Colitis Chronic Moderate | Ulcerative Colitis Chronic SevereUnited States, Austria, Bulgaria, Canada, Georgia, Germany, Hungary, Italy, Korea, Republic of, Poland, Russian Federation, Serbia, Ukraine
-
Theravance BiopharmaCompletedActive Mild Ulcerative Colitis, Active Moderate Ulcerative Colitis, Healthy SubjectsUnited States
-
Rise Therapeutics LLCUniversity of Colorado, Denver; Mayo ClinicRecruitingUlcerative Colitis | Ulcerative Colitis Chronic Moderate | Ulcerative Colitis Chronic | Ulcerative Colitis Chronic MildUnited States
-
Groupe d'Etude Therapeutique des Affections Inflammatoires...CompletedIntensive Treatment to Reach the Target With Golimumab in ulcErative coliTis - In-TARGET (In-TARGET)ULCERATIVE COLITISFrance, Belgium
-
Xijing Hospital of Digestive DiseasesNot yet recruitingUlcerative Colitis Chronic Moderate | Ulcerative Colitis Chronic Severe | Rectal UlcerChina
-
Altheus Therapeutics, Inc.UnknownUlcerative Colitis | Left-sided Ulcerative Colitis | Distal Ulcerative ColitisUnited States
Clinical Trials on JNJ-77242113
-
Janssen Research & Development, LLCActive, not recruitingPlaque PsoriasisUnited States, Korea, Republic of, Germany, France, Taiwan, Japan, Spain, United Kingdom, Poland, Canada
-
Janssen Research & Development, LLCActive, not recruitingPlaque PsoriasisUnited States, Korea, Republic of, Hungary, United Kingdom, Canada, Germany, Poland, Turkey, Taiwan, Spain, Argentina
-
Janssen Pharmaceutical K.K.RecruitingGeneralized Pustular Psoriasis | Erythrodermic PsoriasisJapan
-
Janssen Pharmaceutical K.K.Completed
-
Janssen Research & Development, LLCCompleted
-
Janssen Research & Development, LLCCompletedPlaque PsoriasisUnited States, Canada, Germany, France, Spain, Poland
-
Janssen Research & Development, LLCActive, not recruitingPlaque PsoriasisGermany, United States, Hungary, Italy, Turkey, Korea, Republic of, United Kingdom, China, Taiwan, Poland, Canada, France, Japan, Australia, Spain, Argentina
-
Janssen Research & Development, LLCRecruitingPlaque PsoriasisKorea, Republic of, United Kingdom, United States, Poland, Germany, Brazil, Spain, Taiwan, Hungary, Japan, Canada, Argentina, Australia
-
Janssen Research & Development, LLCRecruitingPlaque PsoriasisUnited States, Korea, Republic of, Taiwan, Germany, Poland, Brazil, Spain, Hungary, Australia, Canada, Romania
-
Janssen Research & Development, LLCCompletedPlaque PsoriasisUnited States, Korea, Republic of, Germany, France, Canada, Japan, Taiwan, Spain, United Kingdom, Poland